D-1044-2014 Class III Terminated
FDA drug recall D-1044-2014 was initiated by Fougera Pharmaceuticals Inc. on Nov 18, 2013 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-Specification degradant results. The recall status is terminated (terminated May 9, 2016). Affected quantity: 31,122 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 5, 2014
- Initiation Date
- Nov 18, 2013
- Termination Date
- May 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 31,122 tubes
Product description
KETOCONAZOLE CREAM, 2%, 30 gram tube, Rx only, E. FOUGERA & CO., A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0099-30, UPC 3 0168-0099-30 9.
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 495P, Exp 07/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1044-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026